Philip D Harvey Selected Research

Lurasidone Hydrochloride

10/2020	Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
12/2017	Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR.
9/2016	Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia.
8/2015	Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation study.
1/2015	The clinical utility of lurasidone in schizophrenia: patient considerations.
4/2014	Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.
11/2013	Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension.
4/2011	Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.
2/2011	Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip D Harvey Research Topics

Disease

76	Schizophrenia (Dementia Praecox) 02/2022 - 03/2002
16	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 12/2002
12	Cognitive Dysfunction 01/2021 - 03/2002
11	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2021 - 05/2005
9	Bipolar Disorder (Manic Depressive Psychosis) 12/2018 - 11/2005
7	Schizotypal Personality Disorder 01/2019 - 05/2003
6	Mental Disorders (Mental Disorder) 01/2022 - 05/2010
5	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 08/2016
4	Neurobehavioral Manifestations 01/2020 - 06/2006
4	Weight Gain 01/2020 - 02/2005
3	Inflammation (Inflammations) 01/2022 - 08/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
2	Wounds and Injuries (Trauma) 01/2021 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 02/2009
2	Hypertension (High Blood Pressure) 04/2020 - 08/2015
2	Hypotension (Low Blood Pressure) 01/2019 - 01/2015
2	Sleepiness 09/2016 - 08/2007
2	Disorders of Excessive Somnolence (Hypersomnia) 09/2016 - 04/2014
2	Personality Disorders (Personality Disorder) 12/2013 - 12/2007
2	Dementia (Dementias) 01/2010 - 10/2005
2	Mania (Manias) 12/2008 - 11/2005
1	Autism Spectrum Disorder 10/2021
1	Insulin Resistance 10/2020
1	Psychomotor Agitation (Akathisia) 01/2020
1	Orthostatic Hypotension (Postural Hypotension) 01/2020
1	Autistic Disorder (Autism) 12/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2018
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2018
1	Treatment-Resistant Schizophrenia 10/2016
1	Overweight 09/2015
1	Brain Neoplasms (Brain Tumor) 05/2015
1	Dizziness (Lightheadedness) 01/2015
1	Tachycardia (Tachyarrhythmias) 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Type 2 Diabetes Mellitus (MODY) 05/2014

Drug/Important Bio-Agent (IBA)

31	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2003
13	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 03/2002
13	ziprasidone (Geodon)FDA Link 04/2011 - 02/2004
10	Quetiapine Fumarate (Seroquel)FDA Link 10/2020 - 11/2006
9	Lurasidone Hydrochloride FDA Link 10/2020 - 02/2011
7	Haloperidol (Haldol)FDA LinkGeneric 01/2019 - 05/2005
7	Olanzapine (Zyprexa)FDA Link 06/2007 - 09/2003
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2014
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2010 - 08/2005
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2022 - 02/2006
4	Biological ProductsIBA 01/2022 - 11/2008
4	roluperidoneIBA 01/2022 - 05/2018
4	VortioxetineIBA 07/2021 - 04/2017
4	Antidepressive Agents (Antidepressants)IBA 01/2021 - 02/2005
4	Pharmaceutical PreparationsIBA 01/2019 - 12/2002
4	Dopamine (Intropin)FDA LinkGeneric 05/2018 - 12/2007
4	LipidsIBA 01/2018 - 02/2005
4	Clozapine (Clozaril)FDA LinkGeneric 10/2016 - 10/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 02/2005
3	GlucocorticoidsIBA 01/2009 - 08/2007
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2021 - 02/2009
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 03/2009
2	ProlactinIBA 01/2020 - 01/2019
2	blonanserinIBA 01/2020 - 01/2019
2	Guanfacine (Tenex)FDA LinkGeneric 01/2019 - 05/2007
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 06/2018 - 06/2014
2	NBI 77860IBA 06/2018 - 06/2014
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2015 - 05/2010
2	fexofenadine (Allegra)FDA LinkGeneric 08/2008 - 05/2003
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2007 - 06/2006
1	Oxytocin (Pitocin)FDA LinkGeneric 02/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	HDL LipoproteinsIBA 10/2020
1	C-Reactive ProteinIBA 10/2020
1	arabinoxylanIBA 04/2020
1	BI 425809IBA 04/2020
1	Glycine Plasma Membrane Transport ProteinsIBA 04/2020
1	pimavanserinIBA 01/2020
1	RitanserinIBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	volinanserinIBA 01/2020
1	lumateperoneIBA 01/2020
1	Estrogens (Estrogen)FDA Link 12/2018
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2017
1	LevomilnacipranIBA 01/2017
1	N- (7- chloro- N- quinuclidin- 3- yl)benzo(b)thiophene- 2- carboxamideIBA 02/2015
1	Nicotine FDA Link 02/2015
1	A-factor (Streptomyces)IBA 01/2015
1	dihydrexidineIBA 01/2015
1	Saline SolutionIBA 01/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2015
1	Corticotropin-Releasing HormoneIBA 06/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2014

Therapy/Procedure

9	Therapeutics 04/2020 - 05/2003
3	Institutionalization (Institutionalized Persons) 01/2018 - 05/2013
2	Ambulatory Care (Outpatient Care) 03/2014 - 09/2004
2	Aftercare (After-Treatment) 12/2008 - 02/2005
1	Precision Medicine 07/2021
1	Transdermal Patch 01/2021
1	Art Therapy 04/2020
1	Cognitive Training 04/2020
1	Drug Therapy (Chemotherapy) 04/2020
1	Long-Term Care 01/2018
1	Resistance Training 09/2015